US · Real Estate · REIT - Healthcare Facilities
EPS came in at 0.16 against a street estimate of 0.16 — a beat of 0.0%.
Analysts rate Sabra Healthcare REIT Inc a buy (6 buy, 7 hold, 0 sell out of 13) with an average price target of $22.71.
| Fund | Stake |
|---|---|
| BlackRock Inc | 15.50% |
| Principal Financial Group Inc | 9.93% |
| Vanguard Portfolio Management, LLC | 9.18% |
| State Street Corp | 4.80% |
| Vanguard Capital Management, LLC | 4.45% |
| JPMorgan Chase & Co | 3.25% |
| Geode Capital Management, LLC | 2.95% |
| Nuveen, LLC | 2.65% |
| Document | Date |
|---|---|
| Reg FD disclosure · Q3 2026 | 2026-07-21 |
| Shareholder vote results · Q2 2026 | 2026-06-17 |
| Reg FD disclosure · Q2 2026 | 2026-05-28 |
| Quarterly report · Q1 2026 | 2026-04-29 |
| Results announced · Q2 2026 | 2026-04-29 |
| Proxy statement · Q2 2026 | 2026-04-24 |
| Annual report FY2025 | 2026-02-12 |
| Quarterly report · Q3 2025 | 2025-11-05 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Sabra Healthcare REIT Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.